Elmon is a leading manufacture of Ballistic (bulletproof) protection. For the last five years Elmon have been working on developing and adding CBRN suits to be included with its products, and are proud about the launching their very own CBRN protection suite with respirator,
...
The Partnership for Research on Ebola Vaccination (PREVAC) has launched a project called PREVAC-UP with the aim of evaluating three Ebola vaccine regimens for five years after vaccination.
The study will assess several factors of these treaments
SIGA Technologies, Inc. today announced that the Canadian Department of National Defence (CDND) has issued an advanced contract award notice (ACAN), indicating that it intends to award a contract to fund regulatory filing with Health Canada for approval of oral TPOXX®.
...
David Norquist, the U.S. Deputy Defense Secretary, has said that American Defense firms should not be cut out of European Union programs to strengthen its industrial base, such as the European Defence Fund and the Permanent Structured Cooperation program.
Speaking at the
...
Merck , known as MSD outside the United States and Canada, today announced that the European Commission has granted a conditional marketing authorization to ERVEBO for active immunization of individuals 18 years of age or older to protect against Ebola Virus Disease (EVD) caused by Zaire Ebola
...
The two-day Chemical Weapons Demilitarisation (CWD) conference supports the global effort to eliminate chemical weapons and fosters co-operation through the exchange of information and ideas relating to safe disposal.
The next CWD Conference will be held in May 2020, London. In addition
...
Avon Protection is pleased to announce that the UK MOD General Service Respirator (‘GSR’) is now in production and work has begun to deliver the first order.
Avon Protection was awarded the 5-year contract to resupply and in-service support for the GSR in February 2018. After a year of
...
Original story from the Pasteur Institute
The Yersinia genus covers a vast range of bacteria that are distinguished by criteria such as whether or not
...
GlaxoSmithKline plc has announced the divestment of travel vaccines Rabipur (tradename Rabavert in the US) for the prevention of rabies, and Encepur for the prevention of tick-borne encephalitis, to Bavarian Nordic.
The decision to divest these brands, acquired from Novartis in 2015 as
...
Porton Biopharma Ltd (PBL) has today announced that it has signed a modification to its contract (HHSN272201600045C) with the US National Institute of Health’s National Institute of Allergy and Infectious Diseases
...
The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) on Thursday allowed the marketing of the first rapid diagnostic test for the Ebola virus that has not been authorized via the agency’s Emergency Use Authorization (EUA) pathway.
The National Institute for Occupational Safety and Health (NIOSH) has released a new virtual toolkit to help first responders reduce their exposure to fentanyl and other illicit drugs. The toolkit provides resources to help keep first responders safe when arriving on a scene where illicit
...
FLIR Systems, Inc. has announced that it has acquired the intellectual property (IP) and certain operating assets of Aria Insights, Inc. Terms of the deal are not being disclosed.
Previously known as CyPhy Works, Inc., Aria pioneered the development of tethered small unmanned aerial
...
The Sabin Vaccine Institute (Sabin) has announced a funding award of $20.5 million with options for an additional $107.5 million from the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services. Under the terms of this agreement,
...
SIGA Technologies, Inc. announced on October 3rd that it has reached concurrence with the US Food and Drug Administration (FDA) that no further clinical studies will be required for the IV formulation of TPOXX (tecovirimat), and SIGA anticipates filing the New Drug Application (NDA) for this
...
It was annonuced on September 24th that the Biomedical Advanced Research and Development Authority (BARDA) intends to provide $14 millio, as well as expertise support for the advanced development of an investigational Ebola treatment being pursued by Ridgeback Biotherapeutics of
...
The FDA has approved the Jynneos vaccine by Bavarian Nordic for the prevention of Smallpox and Monkeypox in adults 18 years of age and older determined to be at high risk for these infections.
Jynneos is a live vaccine produced from the strain Modified Vaccinia Ankara-Bavarian Nordic
...
Emergent BioSolutions Inc. announced on September 25th that it has been awarded approximately $20 million to develop and manufacture an auto-injector containing diazepam (5 mg/mL) to treat nerve agent-induced seizures. Emergent’s device is being designed for intramuscular
...
BioFactura, Inc. announced on September 26th a contract awarded by the Biomedical Advanced Research and Development Authority (BARDA) valued at up to $67.4 million for the advanced development of its Smallpox Biodefense Therapeutic as a potential medical countermeasure (MCM) for the treatment
...
Scientists at the Lawrence Livermore National Laboratory have been working with live agent, supercomputers, and accelerated mass spectrometry, to develop a new nerve agent antidote, namely LLNL-02.
Their work has been showing great promise, and with somw refinement of
...
The U.S. Department of Health and Human Services (HHS) announced this week that they will be purchasing a smallpox vaccine, called ACAM2000, to build and replenish vaccine stored in the ...
As part of the international response to the Ebola virus outbreak in the Democratic Republic of the Congo (DRC) and to meet domestic biodefense goals, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) will support
...
The Department of Homeland Security (DHS)
Pluristem Therapeutics Inc. a leading regenerative medicine company developing novel placenta-based cell therapy products is presenting positive results from a series of studies of the company’s PLX-R18 cell therapy product
...
GeoVax Labs, Inc.has announced positive results (100% protection) from preclinical challenge studies of its Marburg virus vaccine candidate; Marburg virus a critical medical threat against which there is currently no available vaccine or treatment. This study data adds to that showing similar
...
New tools for programmable modulation of gene expression could yield enhanced resilience against influenza and ionizing radiation for service members and first responders.
Breakthroughs in the science of programmable gene expression inspired DARPA to
SIGA Technologies, Inc., a commercial-stage pharmaceutical company focused on the health security market, today announced that it has entered into an international promotion agreement with Meridian Medical Technologies, Inc. Under the agreement, Meridian will promote the sale of oral TPOXX for
...
Valneva SE (“Valneva”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs, and the Coalition for Epidemic Preparedness Innovations (CEPI) hereby announce a new partnering agreement.
With support from the European Union’s (EU’s)
...
CEPI has awarded a contract worth up to US$12.5 million to a consortium led by Wageningen Bioveterinary Research to develop a human vaccine against Rift Valley fever.
Wageningen Bioveterinary Research (WBVR), part of Wageningen University & Research, and the Coalition for
...
SIGA Technologies announced today that they have been awarded a multi-year contract by the U.S. Department of Defense (DOD) to support the work necessary to gain a potential label expansion for TPOXX that would include its use for post-exposure prophylaxis (PEP) for Smallpox.
The
...
The OPCW has been visiting and reporting on the progress at the Pueblo Chemical Agent-Destruction Pilot Plant (PCAPP), in pursuance with decision C-16/DEC.11 “Final Extended Deadline of 29 April 2012”.
The latest report from the OPCW visit in April 2019 is
...
Bavarian Nordic announced on June 19 the initiation of a pivotal Phase 3 trial of the freeze-dried formulation of MVA-BN smallpox vaccine in 1,110 healthy, vaccinia-naïve subjects.
OPEC Systems has announced it has signed a $23 million contract with Leidos Australia to support LAND 2110 Phase 1B of the Chemical, Biological, Radiological, Nuclear Defence (CBRND) Project.
The project, due to be rolled out between January and March 2020, involves the provision of
...
Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced today that the Department of Defense (DOD), through its Platforms for Rapid Integrated Solutions for Medical Countermeasures (PRISM) office, has awarded the company with two contracts
...
AntoXa Corporation has been awarded a contract with the Government of Canada to continue work on production of plant-made butyrylcholinesterase (BuChE), a protein that provides protection against toxic nerve agents such as sarin and soman.
The one-year contract, worth up to
...
The U.S Department of Defense has awarded Avon Protection Systems a contract worth $245m for the production of the M53A1 respirator.
The M53A1 was developed by Avon to counter military unique and domestic threats encountered on the modern battlefield, the global war on
...
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), along with Uniformed Services University of the Health Sciences (USU), Profectus Biosciences, Inc., the Vanderbilt University Medical Center, Mapp Biopharmaceutical, Inc., and
...
Emergent BioSolutions Inc. recently announced the initiation of a Phase 3 trial to evaluate the lot consistency, immunogenicity, and safety of AV7909 (anthrax vaccine adsorbed with CPG 7909 adjuvant) following a two-dose schedule administered intramuscularly in healthy
...
It was announced today that the Coalition for Epidemic Preparedness Innovations (CEPI) and CureVac AG, a biopharmaceutical company pioneering the field of mRNA-based vaccines, have announced a partnership agreement worth up to US$ 34 million for the ongoing development of The RNA Printer
...
Themis Bioscience announced on February 25th that the United States Food and Drug Administration (FDA) has granted fast track designation to the Company’s lead vaccine candidate for the prevention of Chikungunya
...
For the past three years, MyDefence has been hard at work with development of a new type of anti-drone system that can effectively solve the problem of protecting large scale areas against the threat of drones. The system is named KNOX and is a customizable end-to-end
...
Since September 2015 Paul Boyé Technologies has been managing the contract “Provision of specialized CBRN equipment for training first responders” in the scope of CoE project 50 to enhance CBRN preparedness and response capabilities of different countries of the African Atlantic Façade and
...
Med-Eng, LLC, a company of The Safariland Group, has announced it has been awarded a four-year Indefinite Delivery Indefinite Quantity (IDIQ) contract to supply the United States Army with its 2nd generation Advanced Bomb Suit (ABS II) to protect the lives of front line soldiers conducting
...
NIOSH has reopened the comment period for its invitation to manufacturers to take part in an expansion of the PPE-Info database by adding products that protect against fentanyl exposure. Materials related to the expansion and the NIOSH notice
...
FLIR Systems, Inc. has announced it has received a delivery order for 24 U.S. Army Chemical, Biological, Radiological, and Nuclear Dismounted Reconnaissance Sets, Kits, and Outfits (CBRN DR-SKO) systems.
The CBRN DR-SKO system is a set of mission-specific kits that characterize and
...The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) announced today the launch of a $250K Challenge to develop concepts for an escape respirator.
The Escape Respirator Challenge seeks new concepts for an escape respirator solution. This challenge
The US Air Force has started to field its Joint Service Aircrew Mask (JSAM) for helicopter aircraft as part of a larger effort to shield its personnel against contamination from weapons of mass destruction.
The JSAM provides better protection against CBRN contamination and is
DuPont Safety & Construction today announced the launch of Nomex® Comfort, an innovative lightweight fabric combining the legendary flame resistant (FR) protection of Nomex® with enhanced comfort and breathability.
DuPont™ Nomex® is synonymous in the industry with the term protection and...Leidos Australia has awarded a contract to AirBoss Defense for the delivery of protective equipment to the Australian Defence Force’s (ADF) Land 2110 Phase 1B programme.
The Land 2110 Phase 1B CBRN defence capability facilities project will provide force protection to its deployed personnel,...Following a recent pre-clinical study, Inovio have announced that their Ebola Vaccine, INO-4212 provided 100% protection following a challenge with a lethal dose of the Ebola virus.
An article in the Journal of Infectious Diseases highlights that regimens of Inovio’s INO-4212 vaccine
...
How to resolve AdBlock issue?